Century Therapeutics, Inc.
IPSCBiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001850119
Revenue FY2025
$109.0M
Net Income
$(10.0M)
EPS (Basic)
$-0.14
Net Margin
-8.8%
ROE
-6.0%
Total Equity
$159.0M
Shares Out
181M
Century Therapeutics, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
RA Capital Management
RA Capital Management
$43.5M
0.3%
—
Adage Capital Management
Adage Capital Management
$9.3M
0.0%
—
Insider Transactions
Reading stored insider transactions…